Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about ANVS

Recent news which mentions ANVS

< Previous 1 2 3 Next >
Annovis Shares Gain As Late-Stage Parkinson's Disease Study Takes-off
Tickers ANVS
Tags General Health Care Biotech
From Benzinga
Publication Of Peer-Reviewed Study In Journal Of The Alzheimer's Association Could Mark A Significant Step For Longeveron
Tickers ANVS LGVN LLY TECH
Tags Longeveron General Partner Content
From Benzinga
Dear AMC Stock Fans, Mark Your Calendars for Aug. 4
Tickers AMC ANVS GME VIVO
Tags GME Market News AMC
From InvestorPlace
Annovis Bio (ANVS) Stock Soars 6% on Positive FDA Update
Tickers ANVS GME
Tags NYSE:ANVS,NYSE:GME GME Market News
From InvestorPlace
FDA Gives Green Signal To Annovis Bio's Parkinson's Trial With Buntanetap
Tickers ANVS
Tags Trading Ideas Benzinga FDA
From Benzinga
Annovis Bio Gets FDA Nod For Late-Stage Parkinson Disease Study Amendments
Tickers ANVS
Tags Health Care General Movers & Shakers
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Tickers ACRX ALNA ANVS AVRO
Tags ALNA BZI/TFM CNSP
From Benzinga
83 Biggest Movers From Yesterday
Tickers ACLX ADTH AERC AMLX
Tags Pre/Market Outlook LCI CALA
From Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
Tickers ACLX ACRX AERC ANVS
Tags SNMP SRAX IMPP
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2022
Tickers ACCD AJG ANVS ARTA
Tags CMA SLCA JCI
From Benzinga
The Daily Biotech Pulse: FDA Approves Bristol Myers' Oral Heart Disease Drug, European Approval For Merck's Keytruda, Genocea Restructures, Zymeworks' Takeover Bid
Tickers ABBV ALDX ANVS AZN
Tags FNCH Benzinga Penny Stocks
From Benzinga
FDA Guides Annovis Bio For Two Phase 3 Buntanetap Trial In Parkinson's Disease
Tickers ANVS
Tags General Health Care Phase 3 Trial
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Tickers ABEO ALRN ANVS ATHE
Tags Market News BLRX Benzinga
From Benzinga
Annovis Bio on Its Positive Results in Alzheimer's and Parkinson's Clinical Trials
Tickers ANVS BIIB
Tags annovis Bio Biotech ANVS
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Tickers ACRX ANVS BLPH CWBR
Tags LXRX ANVS QNRX
From Benzinga
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
Tickers ADPT AFIB ANVS ATHX
Tags MDNA AFIB Biotech
From Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Tickers ACHV ACIU AEMD AGEN
Tags FDA OMER ISEE
From Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
Tickers ABUS ACAD ACIU ADAP
Tags ALEC ABUS LGND
From Benzinga
92 Biggest Movers From Friday
Tickers AAOI ABNB ADGI ADTX
Tags TRHC RWLK ANVS
From Benzinga
44 Biggest Movers From Yesterday
Tickers ALF AMN ANVS AZYO
Tags DPRO NRXP DNA
From Benzinga
3 Stocks Insiders Are Buying
Tickers ANVS LSCC LTH
Tags Benzinga LTH Trading Ideas
From Benzinga
EXCLUSIVE: Annovis Bio's Parkinson's Candidate Improves Speed, Motor Function Vs Placebo
Tickers ANVS
Tags General News Briefs
From Benzinga
Here's How You Handle a Volatile Stock Like Cassava Sciences
Tickers ANVS INMB SAVA
Tags SAVA Market News ANVS
From Motley Fool
Insiders Like Cassava Sciences, Which Might Be Good News
Tickers ANVS SAVA
Tags SAVA Market News ANVS
From InvestorPlace
The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO
Tickers ABBV ALZN AMRX ANVS
Tags TCRX BTCY ANVS
From Benzinga
Better Biotech Stock: Cassava Sciences vs. Annovis Bio
Tickers ANVS BIIB SAVA
Tags BIIB Market News SAVA
From Motley Fool
Tread Carefully Before Pulling the Trigger on Cassava Sciences
Tickers ANVS SAVA
Tags Market News SAVA ANVS
From InvestorPlace
Why Might Cassava Succeed With Its Alzheimer's Drug, When So Many Have Failed?
Tickers ANVS BIIB SAVA
Tags ANVS SAVA Market News
From Motley Fool
Why Is Biogen Pursuing a New Direction in Alzheimer's Research?
Tickers ANVS AVXL BIIB SAVA
Tags AVXL BIIB SAVA
From Motley Fool
Use Weakness in these 3 Alzheimer’s Disease Stocks as Opportunity
Tickers ANVS AVXL SAVA
Tags Market News SAVA ANVS
From InvestorPlace
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.